|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.02|
Pharmaceutical company called 'toxic' after it slashes guidance on drug-pricing pressure.
But for the brave, they could offer a solid bottom-fishing opportunity.
Glenview Capital's Larry Robbins has hit the nail on the head with his health care picks in recent years, but they're not his only investments you should be watching.
Looking to add even more performance to your portfolio? Consider pharmaceutical stocks with so-called high beta - a common measurement of volatility.
A Landmark Moment as Online Store is Open for Business Now
This small-cap play in retail real estate may be a smart buy for your portfolio.
The Barrel portfolio gets a brand new look, with simplified categories.
Take a look at the winners and losers so far in this portfolio.